This report analyzes real-world GenAI and LLM deployments across pharmaceutical and biotech companies, covering regulatory writing, drug discovery, clinical operations, pharmacovigilance, enterprise productivity, and medical affairs. It profiles initiatives from companies including Moderna, Pfizer, Merck, Novartis, AstraZeneca, and Johnson & Johnson, highlighting use cases such as automated clinical study reports, AI copilots, patient recruitment, protocol optimization, and AI-assisted drug discovery. The report shows strong momentum toward enterprise-scale deployment, with many firms reporting 30–50% efficiency gains, increased automation, and growing preference for internally developed AI platforms over external tools.

Join for free to read